Travere Therapeutics grants inducement equity awards covering 178,580 shares to 33 new hires
Travere Therapeutics reported inducement equity awards covering 178,580 shares for 33 new employees, granted on Oct. 10, 2026. Awards included stock options for 36,000 shares, structured as non-qualified options with a 10-year term. Options vest over four years, with 25% vesting after one year, then monthly vesting ove